Title of article
Dissociation of EphB2 Signaling Pathways Mediating Progenitor Cell Proliferation and Tumor Suppression
Author/Authors
Maria Genander، نويسنده , , Michael M. Halford، نويسنده , , Nan-Jie Xu، نويسنده , , Malin Eriksson، نويسنده , , Zuoren Yu، نويسنده , , Zhaozhu Qiu، نويسنده , , Anna Martling، نويسنده , , Gedas Greicius، نويسنده , , Sonal Thakar، نويسنده , , Timothy Catchpole، نويسنده , , Michael J. Chumley، نويسنده , , Sofia Zdunek، نويسنده , , Chenguang Wang، نويسنده , , Torbjorn Holm، نويسنده , , Stephen P. Goff، نويسنده , , Sven Pettersson، نويسنده , , Richard G. Pestell، نويسنده , , Mark Henkemeyer، نويسنده , , Jonas Frisén، نويسنده ,
Issue Information
هفته نامه با شماره پیاپی سال 2009
Pages
14
From page
679
To page
692
Abstract
Signaling proteins driving the proliferation of stem and progenitor cells are often encoded by proto-oncogenes. EphB receptors represent a rare exception; they promote cell proliferation in the intestinal epithelium and function as tumor suppressors by controlling cell migration and inhibiting invasive growth. We show that cell migration and proliferation are controlled independently by the receptor EphB2. EphB2 regulated cell positioning is kinase-independent and mediated via phosphatidylinositol 3-kinase, whereas EphB2 tyrosine kinase activity regulates cell proliferation through an Abl-cyclin D1 pathway. Cyclin D1 regulation becomes uncoupled from EphB signaling during the progression from adenoma to colon carcinoma in humans, allowing continued proliferation with invasive growth. The dissociation of EphB2 signaling pathways enables the selective inhibition of the mitogenic effect without affecting the tumor suppressor function and identifies a pharmacological strategy to suppress adenoma growth.
Journal title
CELL
Serial Year
2009
Journal title
CELL
Record number
1020064
Link To Document